Showing results (261-270 of 554) with videos related to

Sort By:
Pageof 56
International Journal of Urology : Official Journal of the Japanese Urological Association|April 30, 2017
Exploring the optimal sequence of abiraterone and enzalutamide in patients with chemotherapy-naïve castration-resistant prostate cancer: The Kyoto-Baltimore collaborationNaoki Terada, Benjamin L Maughan, Shusuke Akamatsu, et al.
JCO Precision Oncology|June 30, 2022
PARP Inhibitor Insensitivity to <i>BRCA1/2</i> Monoallelic Mutations in Microsatellite Instability-High CancersEthan S Sokol, Dexter X Jin, Alexander Fine, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 29, 2015
Serial blood-based analysis of AR-V7 in men with advanced prostate cancerM Nakazawa, C Lu, Y Chen, et al.
The Prostate|January 26, 2018
Intraductal/ductal histology and lymphovascular invasion are associated with germline DNA-repair gene mutations in prostate cancerPedro Isaacsson Velho, John L Silberstein, Mark C Markowski, et al.
Clinical Genitourinary Cancer|September 20, 2021
Molecular and Clinical Characterization of Patients With Metastatic Castration Resistant Prostate Cancer Achieving Deep Responses to Bipolar Androgen TherapyMark C Markowski, Sushant Kachhap, Angelo M De Marzo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 28, 2010
Lenalidomide in nonmetastatic biochemically relapsed prostate cancer: results of a phase I/II double-blinded, randomized studyDaniel Keizman, Marianna Zahurak, Victoria Sinibaldi, et al.
Journal of Gastrointestinal Cancer|September 14, 2011
Surgical resection of malignant melanoma metastatic to the pancreas: case series and review of literatureJatinder Goyal, Evan J Lipson, Neda Rezaee, et al.
Oncotarget|March 27, 2013
Tumorigenic potential of circulating prostate tumor cellsFilipe L F Carvalho, Brian W Simons, Emmanuel S Antonarakis, et al.
The Prostate|June 20, 2023
Clinical outcomes in patients with metastatic castrate-resistant prostate cancer treated with abiraterone with or without ongoing androgen deprivation therapy: A retrospective case-control studyAli T Arafa, Leah R Blader, Karan Ramakrishna, et al.
European Urology|May 23, 2017
Preclinical Study using Malat1 Small Interfering RNA or Androgen Receptor Splicing Variant 7 Degradation Enhancer ASC-J9<sup>®</sup> to Suppress Enzalutamide-resistant Prostate Cancer ProgressionRonghao Wang, Yin Sun, Lei Li, et al.
Pageof 56